Sudarshan Pharma Industries: The Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to…
Sudarshan Pharma Industries (SUDARSHAN) filed a disclosure titled "The Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to".
What happened
Sudarshan Pharma Industries (SUDARSHAN) filed a disclosure with the exchanges on 30 October 2026 at 03:05 PM titled "The Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to".
Company snapshot
SUDARSHAN is a listed company.
The stock last traded at ₹35.83, against a 52-week range of ₹34.7–₹39.3 (8.8% below the high).
What history shows
This is not the company's first fund raising disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
Market-wide, 1,676 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.